Infectious Diarrhea: Pathophysiology, Transmission, Clinical Features, and Evidence-Based Treatment Strategies

Infectious diarrhea refers to increased stool frequency and/or decreased stool form caused by enteric pathogens such as bacteria (e.g., Campylobacter, Salmonella, Shigella, enterotoxigenic E. coli), viruses (e.g., norovirus, rotavirus), or parasites (e.g., Giardia). The clinical syndrome varies from self-limited watery diarrhea to dysentery with fever and blood in stool. Despite different etiologies, the underlying mechanisms converge on intestinal epithelial injury, altered ion and water transport, and host inflammatory responses.

Pathogenesis is typically mediated by either toxin-driven secretory processes or invasive injury to the mucosa. Enterotoxigenic bacteria often produce toxins that increase intracellular cyclic AMP or cyclic GMP, driving chloride secretion and impairing sodium absorption, resulting in profuse watery diarrhea. Invasive organisms such as Shigella and some Salmonella strains invade epithelial cells, trigger cytokine release, and recruit neutrophils, producing mucosal ulceration and dysentery. Viral enteritis commonly causes epithelial dysfunction and malabsorption of carbohydrate substrates, contributing to osmotic diarrhea. Parasites like Giardia attach to the small-bowel epithelium, disrupt brush border enzymes, and interfere with nutrient absorption, leading to foul-smelling, bulky stools and weight loss.

Transmission is predominantly fecal–oral via contaminated food or water, contact with infected individuals, and inadequate hand hygiene. Environmental persistence differs by pathogen; for example, norovirus can remain infectious on surfaces and spread efficiently in crowded settings. Host factors strongly influence outcomes. Extremes of age, immunosuppression, inflammatory bowel disease, and reduced gastric acidity increase susceptibility. Antibiotic exposure can also predispose to dysbiosis-related infectious susceptibility and complicate Clostridioides difficile risk, though C. difficile requires its own diagnostic framework.

Clinically, infectious diarrhea is categorized by duration: acute (typically <14 days), persistent (about 14–30 days), and chronic (>30 days). Red flags include high fever, severe dehydration, abdominal tenderness, persistent vomiting, blood or mucus in stool, severe weakness, hypotension, and signs of sepsis. In children, inadequate oral intake, decreased urination, sunken eyes, lethargy, and poor skin turgor suggest clinically significant dehydration. In adults, orthostatic symptoms and reduced urine output are important markers of volume depletion.

Diagnostic evaluation focuses on clinical severity and epidemiology. For most uncomplicated acute cases, stool testing is not immediately required. However, stool culture or multiplex PCR is indicated for dysentery, severe or prolonged illness, outbreaks, immunocompromised patients, or suspected specific pathogens (e.g., C. difficile in appropriate contexts, or stool testing during institutional clusters). Basic labs may include electrolytes, kidney function, and complete blood count in moderate-to-severe cases, particularly where dehydration is suspected. Assessment for dehydration guides urgency and treatment intensity.

Management centers on preventing and correcting dehydration and maintaining nutrition. Oral rehydration solution (ORS) with appropriate osmolarity is first-line and is effective even in many moderately severe cases. For patients with inability to tolerate oral intake or with severe dehydration, intravenous isotonic fluids (e.g., normal saline or balanced crystalloids) are indicated, with careful monitoring of vital signs and electrolytes. Nutritional support should not be withheld; early refeeding, including continued breastfeeding in infants, improves outcomes and reduces duration.

Use of antimicrobial therapy depends on suspected etiology and patient risk. Empiric antibiotics may be considered in select severe cases (e.g., high fever with dysentery, suspected cholera in severe watery diarrhea with dehydration, or certain traveler’s diarrhea syndromes), but routine empiric use for all acute diarrhea is discouraged due to limited benefit in viral disease and the potential for harm via antibiotic-associated complications and resistance. Symptomatic therapy includes antiemetics for vomiting and, in certain situations, antidiarrheal agents such as loperamide for watery diarrhea without fever or blood, acknowledging contraindications in suspected invasive bacterial infection. Bismuth subsalicylate can reduce stool frequency and has mild antimicrobial activity.

Prevention strategies include safe water practices (boiling, filtration, appropriate chlorination), hygienic food handling, handwashing with soap, safe diaper disposal, and vaccination where available (e.g., rotavirus). Public health measures are crucial during outbreaks, especially for highly contagious viral pathogens.

When to seek urgent care includes inability to keep fluids down, signs of dehydration, persistent blood in stool, severe abdominal pain, confusion, high fever, or illness in high-risk groups such as infants, elderly adults, pregnancy, and immunocompromised individuals.

Source: @BeilkePerr6262